noninvasive support in patients who are ready to be weaned but not yet ready for mechanical ventilation to be removed. Because no artificial airway is used with noninvasive ventilation and the cough reflex is preserved, the risk for ventilatorassociated pneumonia is reduced. 9, 10 Additionally, noninvasive weaning may reduce the requirement for sedation, 11 decrease psychological distress 12 and permit speech and oral intake. 13 However, with noninvasive weaning, clinicians must anticipate drying of secretions, accept that only partial ventilatory support can be provided and forfeit a protected airway. Since its initial description as a weaning modality, 14 RCTs and meta-analyses 15, 16 have compared noninvasive ventilation with alternative weaning strategies. A recent guideline suggested that noninvasive ventilation could be used to facilitate early liberation from mechanical ventilation in patients who have COPD at centres with expertise in its use. 17 The purpose of this review was to critically appraise, summarize and update a systematic review and meta-analysis of the effect of noninvasive weaning compared with invasive weaning on important outcomes in light of new evidence.
Methods

Data sources and search criteria
We updated a previously conducted search of MEDLINE (January 1966 We reviewed the reference lists of retrieved articles to identify potentially relevant trials, contacted authors to obtain additional information regarding study methods where needed and searched for ongoing trials at Controlled-trials.com and ClinicalTrials.gov. Ethics approval was not required for this systematic review.
Study selection
We included randomized and quasirandomized trials that enrolled adults with respiratory failure who required invasive mechanical ventilation for at least 24 hours, compared extubation with immediate application of noninvasive ventilation with continued invasive weaning and reported at least one of the following outcomes: mortality (primary outcome), v entilator-associated pneumonia, weaning failure (using authors' definitions), length of stay in the intensive care unit (ICU) or hospital, total duration of ventilation, duration of ventilation related to weaning, duration of invasive ventilation, adverse events or quality of life. We excluded trials that compared noninvasive weaning with invasive weaning in the immediate postoperative setting, compared noninvasive ventilation with unassisted oxygen supplementation or investigated noninvasive ventilation after unplanned extubation.
Data extraction and quality assessment
Two authors (KB, NA), unblinded to the source of the reports, abstracted data regarding study methods (randomization, allocation concealment, completeness of follow-up, selective outcomes reporting) using a standardized form. Disagreements regarding study selection and data abstraction were resolved by consensus and arbitration with a third author (MM).
Data synthesis and statistical analysis
We pooled data across studies using random effects models. We derived summary estimates of risk ratio (RR) and mean difference (MD) with 95% confidence intervals (CIs) for binary and continuous outcomes, respectively, using Review Manager 5.1.6. 18 If an outcome was reported at 2 different times, we included the more protracted measure in pooled analyses.
We evaluated the effect of statistical heterogeneity among pooled studies for each outcome using the Cochran Q statistic (threshold p < 0.10) 19, 20 and the I 2 test 21, 22 with threshold values of 0%-40% (representing heterogeneity that might not be important), and 30%-60%, 50%-90%, and ≥ 75% (representing moderate, substantial or considerable heterogeneity, respectively). 22 If a heterogeneity value overlapped 2 categories, we assigned it the higher rating. In sensitivity analyses, we assessed the effect of excluding quasirandomized trials on estimates of mortality and ventilator-associated pneumonia. We planned subgroup analyses to compare the effects of noninvasive weaning on mortality and weaning failure in studies including only patients with COPD with the effects seen in studies involving patients without COPD or mixed populations. In addition, we compared the effects seen in studies in which at least 50% of the participants had COPD with the effects seen in studies in which less than 50% of participants had COPD. We assessed for differences between subgroup summary estimates using the χ 2 test. 23 We used the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) principles 24 to assess the quality of evidence associated with specific outcomes (mortality, weaning failure, ventilatorassociated pneumonia, duration of ventilation related to weaning and reintubation).
Results
Trial identification
We identified 1506 records in our updated search. Of the 961 unique records we found, we assessed 15 new articles for eligibility (Figure 1) . 16 Although we identified 6 additional trials from our updated search, 1 author confirmed that his trial had been aborted and never published, and 1 trial had not been consistently randomized (see Appendix 2 for a list of the excluded studies, available at www .cmaj .ca /lookup /suppl /doi :10 .1503 /cmaj .130974 /-/DC1). Consequently, we included 4 newly identified trials in our analysis, [25] [26] [27] [28] in addition to the 12 trials included in our previous review. 16 Of the 16 included trials, 2 were published only in abstract form, 29, 30 4 were published in Chinese, [31] [32] [33] [34] 1 was a dissertation subsequently published in full, 35 and one was a pilot RCT. 28 We excluded 20 studies (11 identified through our updated search [ Figure 1 ] and 9 excluded previously; Appendix 2), including 9 newly identified publications, 1 abstract and the aborted trial ( Figure 1 25, 38, 39 in about 30% of patients in 2 trials 29, 40 and in more than 20% of patients in 1 trial; 27 COPD was an exclusion criterion in 1 trial. 28 Patients were considered difficult to wean in 2 trials 25, 38 and had persistent weaning failures in 1 trial. 39 Four trials [32] [33] [34] 37 included patients with COPD whose respiratory failure was due to pulmonary infection. The 2 reviewers achieved complete agreement on study selection.
Quality assessment
Overall, the quality of the included trials was moderate to good (Tables 2 and 3 ). In most of the trials, allocation to the treatment group was by random assignment, with 1 quasirandomized trial Records screened n = 961 Excluded n = 946
• Studies not relevant
Excluded n = 11
• Trial aborted n = 1 • All patients had tracheostomy n = 1
• Not randomized n = 3
• Explored short-term ventilation and/or physiologic outcomes n = 1 • No inspiratory assist in noninvasive group n = 1 • Not noninvasive v. invasive weaning n = 4
Full-text articles assessed for eligibility n = 15
New studies included in analysis n = 4
Studies included in qualitative synthesis n = 16
Excluded n = 553
• Duplicate records
Previously identi ed studies n = 12
Figure 1: Selection of included studies. This review represents an update of a previously conducted systematic review and meta-analysis. 16 Research CMAJ, February 18, 2014, 186(3) E115 Note: COPD = chronic obstructive pulmonary disease, FiO2 = fraction of inspired oxygen, NIV = noninvasive ventilation, PaO2 = partial pressure of oxygen, PAV = proportional assist ventilation, PEEP = positive end-expiratory pressure, PIC = pulmonary infection control, SBT = spontaneous breathing trial, SIMV = synchronized intermittent mandatory ventilation, ST = spontaneous/timed, VPAP = variable positive airway pressure. *Trials evaluating patients with COPD and pulmonary infection, which enrolled patients who achieved PIC window criteria or after infection control was achieved. These criteria included an improved radiograph, temperature and leukocyte count (or percentage of neutrophils), in addition to reduced secretion volume and tenacity. Two trials also speci ed improved hemodynamics, expectoration and level of consciousness; 34,36 1 trial 57 speci ed minimum ventilator settings (SIMV rate 10-12 breaths/min, pressure support 10-12 cm H2O).
allocating patients according to order of hospital admission. 31 We judged allocation concealment to be adequate in 8 trials, [25] [26] [27] [28] [29] [30] 36, 39 unclear in 7 trials [32] [33] [34] [35] 37, 38, 40 and inadequate in 1 quasirandomized trial. 31 In 2 trials, 32,34 denominators were not provided in binary outcomes to ensure complete Note: CI = con dence interval, VAP = ventilator-associated pneumonia. *For weaning failure, reintubation and tracheostomy, the numbers of patients in the denominators differ from sums of numbers in Table 1 because one study 38 reported these outcomes differently (i.e., weaning failure included reintubation or death within 7 d; reintubation included only reintubation within 7 d; tracheostomy was reported in 105 surviving patients at discharge). †Invasive ventilation. ‡Risk ratio. §Mean difference.
reporting. The possibility of selective outcomes reporting was not excluded in 1 trial 31 that reported clinically important outcomes, but did not specify primary and secondary outcomes. Another trial 39 did not report weaning outcomes in the full publication, but did report them in a previously published abstract; the authors affirmed that they had not continued to collect these data (Appendix 3, available at www .cmaj .ca /lookup /suppl /doi :10 .1503 /cmaj .130974 /-/DC1).
Primary outcome
All of the trials provided mortality data, which was reported at 30, 60 and 90 days, 27 
Secondary outcomes
Eight trials involving 605 patients, using variable definitions, reported the proportion of patients successfully weaned. [25] [26] [27] [28] [29] [30] 36, 38 The pooled data showed a significant reduction in the proportion of weaning failures using noninvasive weaning (RR 0.63, 95% CI 0.42 to 0.96) with moderate heterogeneity (I 2 = 38%; p = 0.1) (Figure 3 ). Pooled data from 14 trials (involving 953 patients) [25] [26] [27] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] that reported ventilator-associated pneumonia (for which criteria for the diagnosis were provided in 10 trials 27, [31] [32] [33] [34] [35] [36] [37] 39, 40 ) showed that noninvasive weaning was associated with decreased ventilator-associated pneumonia (RR 0.25, 95% CI 0.15 to 0.43), with moderate heterogeneity (I 2 = 38%; p = 0.07) (Figure 4 , Appendix 4).
Noninvasive weaning significantly reduced the length of stay in both the ICU (MD −5.59 d, 95% CI −7.90 to −3.28) and the hospital (MD −6.04 d, 95% CI −9.22 to −2.87), the total (Table 3) .
Adverse events
The pooled result showed no difference in arrhythmias (RR 0.89, 95% CI 0.34 to 2.34; 3 trials, 201 patients), 25 with variable heterogeneity (Table 3) .
Sensitivity and subgroup analyses
The exclusion of a quasirandomized trial 31 maintained significant reductions in mortality (RR 0.60, 95% CI 0.40 to 0.90) and the rate of ventilator -associated pneumonia (RR 0.27, 95% CI 0.16 to 0.45), favouring noninvasive weaning.
We noted a significant difference in RR between subgroups (p = 0.02) evaluating the effect of noninvasive weaning on mortality in COPD (RR 0.36, 95% CI 0.24 to 0.56; 9 trials) compared with the effect in a mixed population (RR 0.81, 95% CI 0.47 to 1.40; 7 trials). A subgroup analysis comparing trials in which at least 50% of the enrolled participants had COPD (RR 0.47, 95% CI 0.29 to 0.76; 12 trials) with trials in which less than 50% of participants had COPD (RR 0.86, 95% CI 0.47 to 1.58; 4 trials) showed a greater reduction in mortality in the COPD-predominant trials. However, the difference was not significant (p = 0.1). The effect of noninvasive weaning on weaning failure did not differ significantly between trials involving patients with COPD or mixed populations.
Interpretation
We identified 16 trials of moderate to good quality comparing noninvasive and invasive weaning among 994 patients, most of whom had COPD. Compared with invasive weaning, noninvasive weaning significantly decreased mortality, the rates of weaning failures and ventilator-associated pneumonia, the length of stay in the ICU or hospital, the total duration of mechanical ventilation and the duration of invasive ventilation. Although noninvasive weaning had no effect on the duration of mechanical ventilation related to weaning, it significantly reduced tracheostomy and reintubation rates. Excluding a single quasirandomized trial supported the statistically significant reductions in mortality and ventilator-associated pneumonia rates favouring non invasive weaning. Subgroup analyses suggested that the benefits of noninvasive weaning to mortality were significantly greater in trials exclusively enrolling patients with COPD than in trials enrolling mixed populations.
Most of the studies included in our review either exclusively or predominantly involved patients with COPD. 25, 26, [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] Our updated review adds 4 new trials to the evidence base, including 2 large trials, 25 ,26 1 of which exclusively enrolled patients with COPD, 26 and 1 which predominantly enrolled patients with COPD. 25 Patients with chronic airflow limitation may be ideally suited to noninvasive ventilation given its ability to offset respiratory muscle fatigue and tachypnea, augment tidal volume and reduce intrinsic positive end-expiratory pressure. Subgroup analyses for mortality suggested noninvasive weaning conferred significantly greater benefits in patients with COPD. However, inferences from subgroup analyses may be limited by the inclusion of patients with COPD in mixed population studies and the small number of trials comparing the alternative weaning strategies in patients with other causes of respiratory failure. Whether other causes of respiratory failure are as amenable as COPD to noninvasive weaning remains to be determined. Overall, most of the trials in this review were of moderate quality, with 3 trials evaluated to be at low risk of bias and 2 trials considered to be at high risk of bias. The methods used to identify weaning candidates varied among trials, but occurred before randomization and are unlikely to have biased the reported duration of ventilation. Conversely, unequal or inconsistent use of weaning protocols and the frequency with which periods of spontaneous breathing (noninvasive strategy) or spontaneous breathing trials (invasive strategy) were permitted after randomization varied among the included trials. Nonstandardization of weaning protocols in unblinded trials may bias estimates of the duration of ventilation. The administration of sedation may affect the duration of ventilation, 41 and only 1 trial 29 in our review used a sedation protocol.
Compared with our previous systematic review, 16 our updated review contains 4 new trials (2 of which are large), nearly doubles the number of included patients (994 v. 530), especially those with COPD, has narrower confidence intervals around point estimates of effect and shows that noninvasive weaning reduces weaning failure and reintubation rates overall, as well as mortality in the subgroup of patients with COPD. A recent systematic review included 16 trials evaluating bilevel noninvasive ventilation and continuous positive airway pressure to wean patients on invasive ventilation, prevent respiratory failure in postoperative patients ready for extubation, or treat postextubation respiratory failure. 15 Considering the population, the conclusions of that review were similar to those of ours, which included 16 trials focused on noninvasive ventilation (excluding continuous positive airway pressure) to wean patients on invasive ventilation.
Strengths and limitations
Our review was strengthened by an extensive search for relevant trials. We screened citations and abstracted data independently and in duplicate, and attempted to contact lead investigators to clarify study methods and outcomes reporting. Pooling results in a meta-analysis presupposes that the studies are sufficiently similar with respect to populations, interventions, outcome definitions and quality that one could expect a comparable underlying treatment effect. Anticipating heterogeneity across studies in pooling selected outcomes, we planned sensitivity and subgroup analyses. Furthermore, we used random-effects models, which generally give more conservative (wider) confidence intervals and consider both between-study and withinstudy variation. Finally, we reported our findings in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. 42 In summary estimates, we found that noninvasive weaning significantly reduced mortality, length of stay in the ICU and hospital and the total duration of mechanical ventilation. These trends are consistent with, and possibly due to, reduced rates of ventilator-associated pneumonia. However, direct access to respiratory secretions among invasively weaned patients may have resulted in enhanced detection of pneumonia. The disparate mortality (range 11.1% to 60.0%) 29, 30, 35 and ventilator-associated pneumonia rates (6.3% to 59.1%) in the control group, 38,39 the potential for detection bias in assessing ventilator-associated pneumonia, and the total numbers of deaths (173) and cases of ventilator-associated pneumonia (174), which are both below several hundred, 43, 44 may cause our effect estimates to be inflated and thereby limit the strengths of the inferences that can be drawn. Although estimates of the impact of heterogeneity associated with mortality, ventilator associated pneumonia and reintubation were moderate, those associated with most continuous outcomes were considerable; the estimates of impact of heterogeneity were unimportant for arrhythmia and tracheostomy rates. Recognizing that COPD may explain some of the heterogeneity we saw (Table 2 and Figure 2 ), we conducted additional post hoc secondary analyses for all study outcomes, comparing trials enrolling patients with COPD with those enrolling mixed patient populations (Appendix 5, available at www .cmaj .ca /lookup /suppl /doi :10 .1503 /cmaj .130974/-/DC1). Finally, in attempts to optimize the time to successful removal of invasive ventilation, clinicians are challenged by a trade-off between the risks associated with failed extubation and the complications associated with prolonged invasive ventilation. 45 Clinicians may be reluctant to use noninvasive weaning owing to the need to surrender a protected airway, inexperience, concerns regarding the partial support provided by noninvasive ventilation, and the increased risk for ventilatorassociated pneumonia if reintubation is required. 45 
Conclusion
Summary estimates from 16 trials suggest that noninvasive weaning reduces mortality and pneumonia without increasing the risk of weaning failure or reintubation. Moreover, in a subgroup analysis, noninvasive weaning significantly reduced mortality in studies involving patients with COPD compared with studies involving mixed populations. Our results provide the rationale to conduct a large RCT, stratified by COPD status, comparing the alternative weaning strategies. In the meantime, clinicians and cen-tres experienced in using noninvasive ventilation, who are currently using or considering using noninvasive ventilation for weaning patients with COPD may be reassured by our results.
